Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 112Lymphoma 66Lymphoma, Large B-Cell, Diffuse 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Non-Hodgkin 29Lymphoma, Follicular 22Burkitt Lymphoma 22Multiple Myeloma 19Leukemia 16Hodgkin Disease 16Neoplasms 14Neoplasm Metastasis 13Lymphoma, B-Cell 13Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Anaplastic 11Lymphoma, T-Cell 8Lymphoma, B-Cell, Marginal Zone 8Lymphoma, T-Cell, Peripheral 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 4Recurrence 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, AIDS-Related 4Immunoblastic Lymphadenopathy 4Prostate Cancer Metastatic 3Primary Myelofibrosis 3Polycythemia Vera 3Plasmablastic Lymphoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3

Interventions

tofacitinib 7ibrutinib 4Rituximab 4Imatinib Mesylate 3ruxolitinib 2ofatumumab 2obinutuzumab 2nilotinib 2bosutinib 2sodium luminolate 1posaconazole 1pegfilgrastim 1montelukast 1ixekizumab 1fludarabine 1canakinumab 1belumosudil 1baricitinib 1axatilimab 1Voriconazole 1Tomography, X-Ray Computed 1Sofosbuvir 1Sirolimus 1Ribavirin 1Respiratory Function Tests 1Proto-Oncogene Proteins c-raf 1Prednisone 1Photopheresis 1Pentostatin 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bronchiolitis Obliterans Syndrome × Prednisone × Clear all
NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 15 charts
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡